Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

4DX

  • Home
  •  
  • 4DX



  • Most Read
  • Latest Comments
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

    AV uptake leads Audinate to push European expansion through recruiting drive
    Public
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • Opinion

    What the SportsBet-BetEasy merger means for TabCorp and punters
    Public
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

    Why this Tasmanian whisky brand had a record sales quarter
    Public
  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

  • 4DMedical’s tech platform now unambiguously in early commercialisation
    4DMedical’s tech platform now unambiguously in early commercialisation
    • News

  • 4DMedical gains momentum as commercialisation gets underway
    4DMedical gains momentum as commercialisation gets underway
    • News

  • 4DMedical to compete with fairy bread for best Aussie invention
    4DMedical to compete with fairy bread for best Aussie invention
    • News

  • 4DMedical’s clinical pilot program to progress following successful first phase
    4DMedical’s clinical pilot program to progress following successful first phase
    • News

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path

    A growing U.S. demand for faster, AI-powered tools in cardiopulmonary care is opening up substantial commercial opportunities for Australian medtech company 4DMedical (ASX:4DX). The Melbourne-based imaging innovator has secured a significant contract with Intermountain Health—one of the United States’ largest and most respected health systems—for the rollout of its newly FDA-cleared Pulmonary Hypertension Analysis (PHA™)

    Read More
    Public
  • 4DMedical’s tech platform now unambiguously in early commercialisation
    • News

    4DMedical’s tech platform now unambiguously in early commercialisation

    Back in the 1970s the world marvelled as the then revolutionary CT scan and nuclear medicine technologies that allowed health care professionals to gain never-before-seen insights into patients’ diseased lungs. The 3D pictures they provided were high resolution images that were a vast improvement on the 2D (x-rays) and 1D (spirometry) tests previously available. Fast

    Read More
    Public
  • 4DMedical gains momentum as commercialisation gets underway
    • News

    4DMedical gains momentum as commercialisation gets underway

    Unfortunately, COVID seems to be here to stay, with re-infections becoming the new norm, and people dropping like flies. (I, of course, being of superior birth, am yet to contract the spicy flu, but time will tell.) The pandemic saw growth in a few industries like eCommerce, however an interesting subset of pandemic profiteers emerged,

    Read More
    Public
  • 4DMedical to compete with fairy bread for best Aussie invention
    • News

    4DMedical to compete with fairy bread for best Aussie invention

    Australians are a smart bunch. Although the pavlova is disputed, we gladly claim awesome inventions like the black box flight recorder, spray-on skin, the cochlear implant, plastic money and fairy bread (arguably the greatest invention of them all). Whilst I’m not sure much could compete with fairy bread, 4DMedical (ASX: 4DX) are giving it a

    Read More
    Public
  • 4DMedical’s clinical pilot program to progress following successful first phase
    • News

    4DMedical’s clinical pilot program to progress following successful first phase

    Following a particularly well received first phase of their clinical pilot program, medical technology company 4DMedical (ASX: 4DX) is advancing their respiratory imaging platform to Phase 2 of their clinical pilot program. Conducted with Australia’s leading medical imaging provider, I-MED Radiology Network, Phase 1 of the program saw radiologists use 4DMedical’s proprietary XV Lung Ventilation

    Read More
    Public
  • 4D Medical progresses with development of their dedicated lung diagnostics tech
    • News

    4D Medical progresses with development of their dedicated lung diagnostics tech

    Every year traditional methods of lung diagnostics worldwide cost US $31 billion dollars. The arguably outdated technologies include the x-ray (invented in 1895), spirometry (invented in 1846) and CT (invented in 1971). Each has their own pros and cons, yet there remains a strong need for low dose, minimally  invasive, time efficient and cost effective

    Read More
    Public
  • 1
  • 2

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.